Related references
Note: Only part of the references are listed.Polyvalent Immunostimulatory Nanoagents with Self-Assembled CpG Oligonucleotide-Conjugated Gold Nanoparticles
Min Wei et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Surface-Engineered Polyelectrolyte Multilayer Capsules: Synthetic Vaccines Mimicking Microbial Structure and Function
Bruno G. De Geest et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Part II: Targeted Particles for Imaging of Anticancer Immune Responses
Ryan W. Hung et al.
Current Drug Delivery (2012)
Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response
Young-Woock Noh et al.
BIOMATERIALS (2011)
Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates
In-Hyun Lee et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Improvement of different vaccine delivery systems for cancer therapy
Azam Bolhassani et al.
MOLECULAR CANCER (2011)
Targeting Nanosystems to Human DCs via Fc Receptor as an Effective Strategy to Deliver Antigen for Immunotherapy
Luis J. Cruz et al.
MOLECULAR PHARMACEUTICS (2011)
Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration
Asolina Braun et al.
NATURE IMMUNOLOGY (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
Haiyan Li et al.
NATURE NANOTECHNOLOGY (2011)
Part I: Targeted Particles for Cancer Immunotherapy
Samar Hamdy et al.
CURRENT DRUG DELIVERY (2011)
A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer
Dongkyu Kim et al.
ACS NANO (2010)
Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
Mariusz Skwarczynski et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Clinical Significance of Regulatory T Cells and CD8+ Effector Populations in Patients With Human Endometrial Carcinoma
Wen Chun Chang et al.
CANCER (2010)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Steven K. Libutti et al.
CLINICAL CANCER RESEARCH (2010)
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems
Deepa Mohanan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Emerging nanotechnology approaches for HIV/AIDS treatment and prevention
Tewodros Mamo et al.
NANOMEDICINE (2010)
Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
Taylor H. Schreiber et al.
SEMINARS IN IMMUNOLOGY (2010)
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Sachiko Hirosue et al.
VACCINE (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Homogeneous Conjugation of Peptides onto Gold Nanoparticles Enhances Macrophage Response
Neus G. Bastus et al.
ACS NANO (2009)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Bioinspired Colorimetric Detection of Calcium(II) Ions in Serum Using Calsequestrin-Functionalized Gold Nanoparticles
Sunghyun Kim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
Marcin Kortylewski et al.
CANCER RESEARCH (2009)
Antigen presentation by dendritic cells in vivo
Elodie Segura et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Differential Expression of Granzyme B and C in Murine Cytotoxic Lymphocytes
Sheng F. Cai et al.
JOURNAL OF IMMUNOLOGY (2009)
A Combined Chemoimmunotherapy Approach Using a Plasmid-Doxorubicin Complex
Vaishali Bagalkot et al.
MOLECULAR PHARMACEUTICS (2009)
Biodistribution of TNF-α-coated gold nanoparticles in an in vivo model system
Raghav Goel et al.
NANOMEDICINE (2009)
Cancer vaccines: Accomplishments and challenges
Sharmila Pejawar-Gaddy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself
Jiali Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming
Rhys S. Allan et al.
IMMUNITY (2006)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
JA Berzofsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The physiology of the lymphatic system
MA Swartz
ADVANCED DRUG DELIVERY REVIEWS (2001)
The role of complement in inflammation and adaptive immunity
R Barrington et al.
IMMUNOLOGICAL REVIEWS (2001)
Share Paper
